Overview
News
Salaries
Products
People
Growth
Offices
Financials

Overview

FDA-approved Zenflow Spring offers long-lasting BPH relief without side effects or surgical trauma. 62% symptom improvement, 0% reintervention at 12 months.

News

News markets.businessinsider.com 23 days ago
Zenflow Announces U.S. Commercialization Progress with Four Centers Completing Zenflow Spring Implant and Delivery System Procedures
SOUTH SAN FRANCISCO, Calif., Sept. 08, 2026 (GLOBE NEWSWIRE) -- Zenflow, Inc. today announced the first commercial procedures with the Zenflow S...
Read more
Report
News zencoder.ai 9 months ago
Zenflow Zencoder - The AI Coding Agent
Transform AI development with Zenflow
Read more
Report
News zencoder.ai 10 months ago
Zenflow by Zencoder - The AI Coding Agent
Streamline AI development with Zenflow
Read more
Report
News Venturebeat 10 months ago
Zencoder's Zenflow boosts AI coding reliability
Zencoder has launched Zenflow, a free desktop app that orchestrates AI coding agents with structured workflows, spec-driven development, and multi-agent verification-aiming to move teams beyond
Read more
Report
News Pulse 2.0 2 years ago
Zenflow: Medical Device Company Raises $24 Million (Series C)
Zenflow, a medical device company developing a minimally invasive treatment for urinary obstruction caused by an enlarged prostate or benign prostatic hyperplasia (BPH), announced that it had raised a $24 million Series C financing round. The funding roun
Read more
Report
News YahooFinance 5 years ago
Zenflow Launches Pivotal Clinical Trial of Minimally Invasive Spring Treatment for Enlarged Prostate Symptoms
Prospective, multinational, randomized, controlled trial designed to support FDA clearanceSOUTH SAN FRANCISCO, Calif., Oct. 04, 2021 (GLOBE NEWSWIRE) -- Zenflow, Inc., a medical device company developing a minimally invasive treatment for enlarged prostat
Read more
Report

People

Shreya Mehta
Executive Officer, Director
Nicholas Damiano
Executive Officer, Director
Nick Damiano
Executive Officer, Director
John Beck
Executive Officer
Bryan Kim
Director
Robert Weisskoff
Director
Radu Cautis
Director
Andrew Cleeland
Director
Susan Stimson
Director
Blayne Roeder
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
South San Francisco United States
HQ
Contact Us
50-200 est. staff
395 Oyster Point Blvd., Suite 501 , South San Francisco, CA 94080 USA
company site

Financials

Total raised
$106.8M
Latest round
Venture - Series Unknown
Funding rounds
4
Funding rounds
Round Announced Amount
Venture - Series Unknown 2024 $19.4M Details
Venture - Series Unknown 2021 $24.4M Details
Venture - Series Unknown 2017 $31.5M Details
Venture - Series Unknown 2017 $31.5M Details